H5N1 Influenza Vaccine

Riik: Uus-Meremaa

keel: inglise

Allikas: Medsafe (Medicines Safety Authority)

Toimeaine:

Influenza Virus Type A haemagglutinin 30ug (Pandemic influenza virus haemagglutinin)

Saadav alates:

Seqirus (NZ) Ltd

INN (Rahvusvaheline Nimetus):

Influenza Virus Type A haemagglutinin 30 µg (Pandemic influenza virus haemagglutinin)

Annus:

30 mcg/0.5mL

Ravimvorm:

Suspension for injection

Koostis:

Active: Influenza Virus Type A haemagglutinin 30ug (Pandemic influenza virus haemagglutinin) Excipient: Aluminium as aluminium phosphate adjuvant Calcium chloride Dibasic sodium phosphate Monobasic potassium phosphate Monobasic sodium phosphate Potassium chloride Sodium chloride Thiomersal Water for injection

Retsepti tüüp:

Prescription

Valmistatud:

Seqirus Pty Ltd

Näidustused:

Prophylaxis of influenza in an officially declared pandemic situation. The vaccine may only be marketed or distributed in accordance with the directive contained in the current version of the New Zealand Influenza Pandemic Action Plan.

Toote kokkuvõte:

Package - Contents - Shelf Life: Vial, glass, multi-dose, - 10 mL - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) protect from light

Loa andmise kuupäev:

2017-01-04